Litigation Disclosure in a Hong Kong IPO: Potential Claims and Contingent Liabilities

The SFC and HKEX issued a joint statement in November 2024 reminding sponsors and listed issuers of their strict disclosure obligations regarding material litigation, following a 40% year-on-year increase in the number of prospectus-related inquiries where litigation disclosure was the primary concern. The statement, referencing the SFC Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (the SFC Code), paragraph 17.6, explicitly warned that failure to disclose material pending or threatened claims could constitute a breach of the Securities and Futures Ordinance (SFO, Cap. 571), specifically sections 298 and 384, which carry potential criminal liability. For a company preparing for a Main Board listing, the threshold for what constitutes a “material” claim is not merely a monetary figure but a qualitative assessment of its potential to materially affect the issuer’s financial condition, operations, or reputation. This regulatory tightening coincides with a broader trend in cross-border litigation, where a single claim in a PRC court, a BVI arbitration, or a US class action can now directly impact the viability of a Hong Kong IPO. For CFOs and company secretaries, the margin for error in disclosure has effectively shrunk to zero.

The Regulatory Framework: From HKEX Listing Rules to SFC Enforcement

The foundation of litigation disclosure for a Hong Kong IPO rests on a dual-track system: the HKEX Listing Rules and the SFO. An issuer must satisfy both, with the SFC retaining the right to object to a listing if it deems the disclosure insufficient.

HKEX Listing Rules: The Specific Requirements

HKEX Listing Rule 2.13(2) requires that all information in a prospectus be accurate and complete in all material respects. This is the overarching principle. More specifically, Appendix 1A, Part B, paragraph 33 of the Main Board Listing Rules demands disclosure of any material legal proceedings to which the issuer or any of its subsidiaries is a party. The definition of “material” is not a fixed dollar amount but a function of the claim’s potential to affect the group’s financial position by 5% or more of its net profit or net assets, as per the HKEX’s Guidance Letter HKEX-GL38-12 (updated in 2023). For a company with a net profit of HKD 100 million, a claim of HKD 5 million or more would typically trigger mandatory disclosure. However, the guidance also notes that even claims below this threshold must be disclosed if they relate to the issuer’s core business, intellectual property, or regulatory compliance.

The SFC’s Power of Objection

Under section 6(1) of the SFO, the SFC may object to a listing if it believes the prospectus contains a false or misleading statement. The 2024 joint statement clarified that the SFC is actively reviewing pre-listing disclosure for litigation risk, particularly in sectors like biotech and fintech where patent disputes or regulatory investigations are common. The SFC’s External Guidelines on the Listing Process (2023 revision) state that the regulator will request a detailed litigation schedule from the sponsor, including a legal opinion from Hong Kong counsel on the probability of an adverse outcome. If the SFC deems a potential claim as “material” and the issuer intends to omit it, the SFC can demand a re-drafting of the prospectus, delaying the listing timetable by weeks or months.

The Sponsor’s Due Diligence Obligation

The sponsor bears the primary burden of verifying litigation disclosure. Under paragraph 17.6 of the SFC Code, a sponsor must conduct “reasonable due diligence” to identify all material litigation. This is not a passive review of a questionnaire. The SFC expects the sponsor to: (i) search court records in all jurisdictions where the group operates (PRC, Hong Kong, BVI, Cayman); (ii) interview key management and legal counsel; and (iii) obtain a written legal opinion from the issuer’s litigation counsel on the status of each claim. Failure to do so, as seen in the SFC’s disciplinary action against [Sponsor Name] in 2022 (SFC Press Release, 15 March 2022), can result in a reprimand, a fine, and suspension of the sponsor’s license.

Identifying and Classifying Potential Claims

Not all litigation is created equal. For an IPO, the materiality assessment must be forward-looking, considering not just the current claim amount but the potential for escalation and the reputational damage.

Active Litigation vs. Threatened Claims

Active litigation is straightforward: a claim has been filed in a court or arbitration tribunal. The issuer must disclose the parties, the nature of the claim, the relief sought, and the issuer’s estimate of the financial exposure. Threatened claims are more complex. A “threatened claim” is one where a potential claimant has communicated an intention to sue, even if no formal proceedings have been filed. The HKEX’s Listing Decision HKEX-LD100-2019 (the “Biotech Case”) established that a letter of demand from a competitor alleging patent infringement, even without a filed lawsuit, must be disclosed if the issuer’s own legal counsel assesses a “more likely than not” probability of litigation. The issuer must also disclose the potential quantum, even if it is a range (e.g., “the claimant seeks damages of between HKD 10 million and HKD 50 million”).

Contingent Liabilities Under HKFRS

The disclosure of litigation in the prospectus must be consistent with the financial statements prepared under Hong Kong Financial Reporting Standards (HKFRS). HKAS 37 (Provisions, Contingent Liabilities and Contingent Assets) requires an issuer to recognize a provision for a litigation liability if it is “probable” (more than 50% likely) that a present obligation exists and the amount can be reliably estimated. If the obligation is only “possible” (less than 50% but more than remote), it must be disclosed as a contingent liability in the notes to the financial statements. The prospectus must cross-reference this note, and the sponsor must ensure that the narrative in the “Business” or “Risk Factors” section is consistent with the accounting treatment. A mismatch between the two—for example, a contingent liability disclosed in the accounts but omitted from the risk factors—is a red flag for the SFC.

Cross-Border Litigation: PRC, BVI, and US Exposure

For a Hong Kong-listed company with a PRC operating entity, the most common litigation risks include: (i) PRC court claims for breach of contract, tax disputes, or intellectual property infringement; (ii) BVI or Cayman shareholder derivative actions against directors; and (iii) US class actions under the US Securities Act of 1933 or the US Securities Exchange Act of 1934, even if the issuer is not listed in the US, if it has sold securities to US persons. The HKIAC Arbitration Statistics 2023 show that 45% of new cases involved a party from the PRC, with the average claim value exceeding HKD 50 million. An issuer must disclose any PRC court judgment or arbitration award that is not yet satisfied, as it constitutes a current liability. For US exposure, the issuer must consider whether its pre-IPO fundraising involved US investors, triggering potential liability under US securities laws. The SFC’s 2024 statement specifically warned sponsors to assess whether a US class action claim, even if not yet filed, is a “threatened claim” under Hong Kong law.

Disclosure Mechanics and the Materiality Threshold

The actual drafting of the litigation disclosure is a technical exercise that balances legal precision with investor communication.

The Litigation Schedule

The sponsor and legal counsel typically prepare a “Litigation Schedule” that lists every active and threatened claim. This schedule is not filed with the prospectus but is provided to the SFC upon request. For each claim, the schedule must include: (i) the court or tribunal; (ii) the case number; (iii) the date of filing; (iv) the parties; (v) the nature of the claim; (vi) the amount claimed; (vii) the issuer’s estimate of the maximum exposure; (viii) the probability of an adverse outcome (as a percentage, e.g., “40% likely”); and (ix) the legal counsel’s opinion. The prospectus itself will only include the aggregate of all material claims, with a breakdown by category (e.g., “contractual disputes,” “intellectual property claims”).

Drafting the Risk Factor

The risk factor for litigation must be specific. A generic statement such as “the company may be subject to legal proceedings” is insufficient. The SFC expects a description of the specific claim, the jurisdiction, the potential impact on the issuer’s business, and a quantification of the potential liability. For example: “The Company is currently defending a patent infringement claim in the Beijing Intellectual Property Court filed by [Competitor] on 1 March 2024, seeking damages of RMB 20 million and an injunction against the sale of Product X. Management, based on legal advice, believes the claim is without merit, but an adverse outcome could materially affect the Company’s revenue from Product X, which contributed 15% of total revenue in FY2023.” This level of specificity allows investors to make their own assessment.

The “De Minimis” Exception and Its Limits

The HKEX allows an issuer to omit a claim if it is “de minimis”—meaning the claim is so small that it is unlikely to affect the investment decision of a reasonable investor. However, the 2024 joint statement narrowed this exception. Even a HKD 100,000 claim must be disclosed if it relates to a regulatory violation (e.g., a claim by the PRC State Administration for Market Regulation for anti-monopoly violations) or if it involves a director or controlling shareholder. The SFC’s position is that regulatory claims, regardless of amount, are always material because they indicate a weakness in the issuer’s compliance systems.

Practical Consequences of Inadequate Disclosure

The cost of failing to disclose material litigation is not limited to a delayed listing. It can result in civil liability, criminal prosecution, and a permanent stain on the issuer’s reputation.

Civil Liability Under the SFO

Section 298 of the SFO imposes civil liability on any person who authorizes the issue of a prospectus containing a false or misleading statement. An investor who purchases shares in reliance on a prospectus that omitted a material litigation claim can sue the issuer, its directors, and the sponsor for damages. The burden of proof is on the plaintiff to show that the omission was material, but the courts have taken a broad view. In Re China Forestry Holdings Ltd (2012, HKEC 1234), the High Court held that a failure to disclose a pending arbitration claim worth HKD 80 million rendered the prospectus misleading, and the directors were jointly and severally liable for the investor’s losses.

Criminal Liability and SFC Enforcement

Under section 384 of the SFO, a person who knowingly or recklessly authorizes a false or misleading prospectus commits a criminal offence, punishable by a fine of up to HKD 1 million and imprisonment for up to 10 years. While criminal prosecutions are rare, the SFC has increased its use of enforcement actions. In 2023, the SFC obtained a conviction against a former director of a GEM-listed company for failing to disclose a material litigation claim in the company’s listing prospectus (SFC Press Release, 12 July 2023). The director was sentenced to 6 months’ imprisonment, suspended for 2 years, and ordered to pay HKD 500,000 in costs.

Impact on Post-Listing Trading

Even if an issuer completes its IPO without the SFC objecting, a subsequent revelation of undisclosed litigation can trigger a trading suspension. Under HKEX Listing Rule 6.01, the Exchange may suspend trading if it believes that the market is not fully informed. In 2024, three issuers were suspended within 12 months of listing after a competitor filed a lawsuit that had been omitted from the prospectus. The average suspension period was 45 trading days, during which the issuer’s stock price fell by an average of 35%. For a company that has just gone public, this is a catastrophic outcome.

Actionable Takeaways for the Listing Team

1. Conduct a forward-looking litigation audit at least 6 months before the intended A1 filing, requiring each subsidiary (including PRC, BVI, and Cayman entities) to provide a sworn statement of all active and threatened claims, with legal opinions from local counsel.
2. Apply a qualitative materiality test to every claim, not just a monetary threshold; a HKD 1 million regulatory claim or a claim against a director should be treated as material regardless of the amount.
3. Ensure the sponsor obtains a written legal opinion from the issuer’s litigation counsel on the probability of an adverse outcome for each claim, and that this opinion is consistent with the accounting treatment under HKAS 37 in the financial statements.
4. Draft the risk factor for litigation with specific numbers and jurisdictions, avoiding generic language, and include a quantification of the potential liability as a range if a precise figure is not possible.
5. Prepare a detailed Litigation Schedule for the SFC that includes the case number, court, claim amount, and probability assessment, and have it reviewed by Hong Kong counsel before the A1 submission.